Concepedia

Author

Kazuya Miyagawa

Stanford UniversityORCID

Also Known As

K Miyagawa, K. Miyagawa, Kazuya Miyagawa

42

Publications

1.5K

Citations

15

H-Index

31

Concepts

All Affiliations

Stanford UniversityKobe Pharmaceutical UniversityKobe UniversityCardiovascular Institute of the SouthCardiovascular Institute Hospital
KM

About

Kazuya Miyagawa is an author at Stanford University specializing in medicine, vascular biology, and pulmonary vascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

279

2

Public Health

2

2

31

3

Cell Biology

2

2

226

4

Biochemistry

1

1

35

5

Pharmacology

1

1

35

Kazuya Miyagawa

×

15

Publications

1.4K

Citations

14

H-Index

YearCitations

Endothelial Cell–Derived Endothelin-1 Promotes Cardiac Fibrosis in Diabetic Hearts Through Stimulation of Endothelial-to-Mesenchymal Transition

Bambang Widyantoro, Noriaki Emoto, Kazuhiko Nakayama,

Circulation

2010

375

BMPR2 Preserves Mitochondrial Function and DNA during Reoxygenation to Promote Endothelial Cell Survival and Reverse Pulmonary Hypertension

Isabel Diebold, Jan K. Hennigs, Kazuya Miyagawa,

Cell Metabolism

2015

213

Elafin Reverses Pulmonary Hypertension via Caveolin-1–Dependent Bone Morphogenetic Protein Signaling

Nils Nickel, Edda Spiekerkoetter, Mingxia Gu,

American Journal of Respiratory and Critical Care Medicine

2015

158

Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension

Yu Taniguchi, Kazuya Miyagawa, Kazuhiko Nakayama,

EuroIntervention

2014

122

Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension

Pin-I Chen, Aiqin Cao, Kazuya Miyagawa,

JCI Insight

2017

99

RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension

Christopher J. Rhodes, Hogune Im, Aiqin Cao,

American Journal of Respiratory and Critical Care Medicine

2015

84

PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension

Jan K. Hennigs, Aiqin Cao, Caiyun G. Li,

Circulation Research

2020

80

An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension

Gusty Rizky Teguh Ryanto, Koji Ikeda, Kazuya Miyagawa,

Nature Communications

2021

61

<i>FHIT</i> , a Novel Modifier Gene in Pulmonary Arterial Hypertension

Svenja Dannewitz Prosseda, Xuefei Tian, Kazuya Kuramoto,

American Journal of Respiratory and Critical Care Medicine

2018

47

Noninvasive and Simple Assessment of Cardiac Output and Pulmonary Vascular Resistance With Whole-Body Impedance Cardiography Is Useful for Monitoring Patients With Pulmonary Hypertension

Yu Taniguchi, Noriaki Emoto, Kazuya Miyagawa,

Circulation Journal

2013

43

Page 1